NEM
53
5
PAYX
44
6
PBI
35
2
PH
57
4
ALLE
19
3
K
65
2
CB
41
2
EXR
37
15
HAL
36
-7
FTI
81
3
LB
64
4
RL
73
-2
TXN
38
3
WBA
43
-5
IBM
48
-2
DFS
68
-2
FCX
40
5
VTR
35
4
NEE
41
2
ITW
33
2
NEM
53
5
PAYX
44
6
PBI
35
2
PH
57
4
ALLE
19
3
K
65
2
CB
41
2
EXR
37
15
HAL
36
-7
FTI
81
3
LB
64
4
RL
73
-2
TXN
38
3
WBA
43
-5
IBM
48
-2
DFS
68
-2
FCX
40
5
VTR
35
4
NEE
41
2
ITW
33
2
Financhill
Back

Colgate-Palmolive Vs. Janux Therapeutics Industry Stock Comparison

Sell
43

CL
Colgate-Palmolive

Last Price:
$87.45
Seasonality Move:
4.23%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Sell
43
Colgate-Palmolive (CL) is a Sell

Is Colgate-Palmolive a Buy, Sell or Hold?

  • The current Colgate-Palmolive [CL] share price is $87.46. The Score for CL is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • CL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CL Stock Price Chart

What is Colgate-Palmolive's stock price today?

  • The Colgate-Palmolive share price today is $87.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CL is experiencing buying pressure, which is a positive indicator for future bullish movement.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

CL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.64 Sell
Relative Strength Index (14 RSI): 24.38 Sell
Chaikin Money Flow: 3216953 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (89.98 - 94.24) Sell
Bollinger Bands (100): (92.37 - 103.71) Sell

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

CL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 89.58 Sell
20-day SMA: 91.55 Sell
50-day SMA: 92.99 Sell
200-day SMA: 96.16 Sell
8-day EMA: 89.23 Sell
20-day EMA: 91.07 Sell
50-day EMA: 93.47 Sell
200-day EMA: 94.02 Sell

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

Colgate-Palmolive Earnings Growth & CL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.32 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

Colgate-Palmolive Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):